Sterling Overview
19th Nov 2021
At Sterling Pharma Solutions, we draw on over 50 years of experience in API development and manufacturing to provide our customers with a full range of API services. This is complimented by decades of combined experience in ADCs and bioconjugation.
What sets Sterling apart?
Together, our scientific and engineering expertise, collaborative customer engagement model, and world-class facilities enable us to develop and execute programmes that are marked by exceptional product quality, seamless scale-up, and safe and sustainable processes.
Through our Technology and Innovation Programme, we continually embrace new and adjacent technologies to enhance our service offerings and deliver greater value.
Our services are grounded in a long history of development, scale-up and manufacture of a wide range of chemical transformations with particular emphasis of challenging and complex chemistries.
We are proud of our compliance record. We prioritise doing the right thing to ensure the safety, quality and sustainability of our processes for people and planet.
From lab to large scale manufacture, our comprehensive range of scales allows us to support customers’ multi-stage, complex processes.
We are true service providers, delivering a partnership experience marked by transparency, collaboration, and trust.
We deliver superior service to our customers by applying the lessons we have learnt over our 50+ year history to all that we do.
We are a PDMO, or partnership development and manufacturing organisation, differentiated by our commitment to:
Sterling is more than a traditional CDMO.
Service
We pride ourselves on being easy to do business with, removing layers of complexity, maximising flexibility and adaptability to your requirements, and doing what we say we will do, again and again.
Passion
We promise to treat your molecule as our own, drive progress by continually exploring new and emerging capabilities, and do the right thing for our people and planet.
Science
We combine our expertise in complex and hazardous chemistry, our world-class facilities, and our full-lifecycle capabilities to place scientific excellence at the core of every solution we deliver.
Our world-class facilities in the UK and US offer world class expertise and true scientific collaboration:
Cary, North Carolina, US
– Opened in 1994
– 2,508m² site- 40+ employees
– FDA approved (2018)
– Approved for schedule 1 to 5 controlled substances
Deeside, Wales, UK
– Opened in 2010
– 6,500m² site
– 40+ employees
– 35 years’ combined ADC experience
– Developed and transferred ten clinical processes into GMP
Dudley, Northumberland, UK
– Opened in 1969
– 42 acre site
– 565+ employees
– FDA approved (2018, 2014, 2011); MHRA approved (2021, 2019, 2017, 2013)
– Approved for schedule 1 to 5 controlled substances
Germantown, Wisconsin, US
– Opened in 1999
– 19,510m² site
– 200+ employees
– FDA approved (2016, 2013, 2011)
– Approved for schedule 1 to 5 controlled substances
Ringaskiddy, Ireland, EU
– Opened in 1994
– 111 acre site
– 378+ employees
– 3 API manufacturing buildings
– 175m3 reactor capacity
Newcastle Biosphere, UK
– Formed in 2002
– 1,442sq/ft site
– 18+ employees
– API discovery and early phase chemistry services
